v3.26.1
Note 10 - Stock-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 6 Months Ended 27 Months Ended
Jul. 31, 2026
Jun. 24, 2026
Apr. 02, 2026
Mar. 27, 2026
Feb. 20, 2026
Jan. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares)             110,842 [1]   110,842 [1] 45,834
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) [2]             $ 9.27      
The PAVmed 2014 Equity Plan [Member]                    
Common Stock, Capital Shares Reserved for Future Issuance (in shares)             1,713,517   1,713,517  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)             583,351   583,351  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)       1,500,000   49,784        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures (in shares)         37,500          
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)         $ 9.47          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)         $ 7.69   $ 6.79 $ 12.6    
The PAVmed 2014 Equity Plan [Member] | Subsequent Event [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures (in shares) 223,500                  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) $ 4.95                  
The PAVmed 2014 Equity Plan [Member] | Share-Based Payment Arrangement, Option [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)             10 years      
The PAVmed 2014 Equity Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Tranche One [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage         33.33%   33.33%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)         1 year   1 year      
The PAVmed 2014 Equity Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Subsequent Event [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 33.33%                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) 1 year                  
The PAVmed 2014 Equity Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage         66.67%   66.67%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)         2 years   2 years      
The PAVmed 2014 Equity Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Subsequent Event [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 66.67%                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) 2 years                  
The PAVmed 2014 Equity Plan [Member] | Restricted Stock [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)         46,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Granted         $ 0.4          
The PAVmed 2014 Equity Plan [Member] | Restricted Stock [Member] | Directors and Certain Officers [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)     889,650              
Share Based Compensation Arrangement By Share Based Payment Award, Non Option Equity Instruments, Granted in Period, Aggregate Fair Value     $ 8.8              
The PAVmed 2014 Equity Plan [Member] | Restricted Stock [Member] | Subsequent Event [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares) 60,000                  
Share Based Compensation Arrangement By Share Based Payment Award, Non Option Equity Instruments, Granted in Period, Aggregate Fair Value $ 0.3                  
Outside of The PAVmed 2014 Equity Plan [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares)             1,446   1,446 1,816
Outside of The PAVmed 2014 Equity Plan [Member] | Stock Options and Restricted Stock Awards [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number (in shares)             1,446   1,446  
PAVmed ESPP [Member]                    
Common Stock, Capital Shares Reserved for Future Issuance (in shares)             221,112   221,112  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)             215,774   215,774  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)   200,000       5,667        
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)                 0  
[1] The outstanding stock options presented in the table above are inclusive of 1,816 stock options granted outside the PAVmed 2014 Equity Plan, as of March 31, 2026 and December 31, 2025.
[2] Stock options granted under the PAVmed 2014 Equity Plan and those granted outside such plan generally vest one-third in one year then ratably over the next eight quarters, and have a ten-year contractual term from date-of-grant.